Owlet, Inc. (OWLT)

USD 4.46

(-4.9%)

Operating Expenses Summary of Owlet, Inc.

  • Owlet, Inc.'s latest annual operating expenses in 2023 was 51.21 Million USD , down -52.8% from previous year.
  • Owlet, Inc.'s latest quarterly operating expenses in 2024 Q1 was 12.28 Million USD , down -5.24% from previous quarter.
  • Owlet, Inc. reported a annual operating expenses of 107.9 Million USD in annual operating expenses 2022, up 18.83% from previous year.
  • Owlet, Inc. reported a annual operating expenses of 90.8 Million USD in annual operating expenses 2021, up 111.81% from previous year.
  • Owlet, Inc. reported a quarterly operating expenses of 12.28 Million USD for 2024 Q1, down -5.24% from previous quarter.
  • Owlet, Inc. reported a quarterly operating expenses of 11.2 Million USD for 2023 Q3, down -6.18% from previous quarter.

Annual Operating Expenses Chart of Owlet, Inc. (2023 - 2019)

Historical Annual Operating Expenses of Owlet, Inc. (2023 - 2019)

Year Operating Expenses Operating Expenses Growth
2023 51.21 Million USD -52.8%
2022 107.9 Million USD 18.83%
2021 90.8 Million USD 111.81%
2020 42.86 Million USD 7.01%
2019 40.06 Million USD 0.0%

Peer Operating Expenses Comparison of Owlet, Inc.

Name Operating Expenses Operating Expenses Difference
Abbott Laboratories 15.71 Billion USD 99.674%
Allurion Technologies Inc. 120.57 Million USD 57.521%
Artivion, Inc. 223.43 Million USD 77.076%
Avanos Medical, Inc. 375.5 Million USD 86.36%
Butterfly Network, Inc. 162.46 Million USD 68.474%
Butterfly Network, Inc. 162.46 Million USD 68.474%
Bio-Rad Laboratories, Inc. 1.04 Billion USD 95.111%
Boston Scientific Corporation 7.47 Billion USD 99.315%
Perspective Therapeutics, Inc. 17.42 Million USD -193.923%
CONMED Corporation 564.24 Million USD 90.923%
Edwards Lifesciences Corporation 3.09 Billion USD 98.343%
Paragon 28, Inc. 210.1 Million USD 75.622%
Glaukos Corporation 367.83 Million USD 86.076%
Globus Medical, Inc. 887.16 Million USD 94.227%
Inspire Medical Systems, Inc. 568.49 Million USD 90.99%
Integer Holdings Corporation 250.95 Million USD 79.591%
Medtronic plc 16.12 Billion USD 99.682%
Nevro Corp. 389.36 Million USD 86.846%
Penumbra, Inc. 590.87 Million USD 91.332%
Vicarious Surgical Inc. 80.66 Million USD 36.505%
Smith & Nephew plc 3.46 Billion USD 98.523%
Sonendo, Inc. 68.46 Million USD 25.19%
STERIS plc 1.4 Billion USD 96.342%
Stryker Corporation 9.2 Billion USD 99.444%
Vapotherm, Inc. 66.02 Million USD 22.425%
Zimmer Biomet Holdings, Inc. 3.27 Billion USD 98.437%